News
Uncertainty around ELEVIDYS sales impact Sarepta Therapeutics, Inc. Click here to find out why I downgraded SRPT stock to a ...
The CHMP recommends conditional marketing authorization for Duvyzat to treat Duchenne muscular dystrophy in patients aged 6 ...
Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts ...
A new study led by researchers at the Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...
Sarepta has submitted a request to the FDA to include the death case in Elevidys’ label, and the agency plans to review the ...
12d
News-Medical.Net on MSNExisting therapies may help control chronic muscle inflammation in Duchenne muscular dystrophyA new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...
Country superstar Alan Jackson has been battling Charcot-Marie-Tooth disease for more than a decade, but he didn't go public ...
whether there's something targeted to their exact genetic mutation. An example of that would be a stop code on read through for Duchenne muscular dystrophy, which was a treatment that was ...
Muscular dystrophy, as a category, is quite diverse. There's dozens of disorders that ... But unfortunately, none are a cure, and we still have very severe symptoms that we're managing with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results